DrCannabinoid.fr: The one-stop-shop for recreational CBD products
With the launch of its new e-commerce site, DrCannabinoid.fr, recreational users of hemp-derived products will be in for a treat as they explore a diverse range of products that go beyond the standard selection of simple cannabidiol. In addition to flowers, hash, and cartridges, the platform offers an intriguing selection of lesser-known cannabinoids such as THCP, THCV, H4CBD, and D9. Let’s take a closer look at the unique properties of these cannabinoids.
THCP (Tetrahydrocannabiphorol)
The THCP is a recently discovered cannabinoid that has sparked keen interest within the scientific community. THCP differs from traditional THC (tetrahydrocannabinol) in its molecular structure, which allows it to bind more effectively to the body’s cannabinoid receptors. As a result, THCP may have a more potent effect than ordinary THC, although research is still in its early stages when it comes to fully understanding its properties.
THCV (tetrahydrocannabivarin)
The THCV is another cannabinoid a fascinating compound found in cannabis plants. Unlike THC, which is known for its psychoactive properties, THCV is said to have the opposite effect at low doses, acting as an appetite suppressant and potentially aiding in weight management. However, at higher doses, it can produce psychoactive effects similar to those of THC.
H4CBD (Cannabidiol Hydroquinone)
The H4CBD is a CBD derivative which has undergone a unique chemical process resulting in Cannabidiol Hydroquinone. Although research on H4CBD is limited, early studies suggest that it may have increased potency and effects that are potentially different from those of traditional CBD. As with any new cannabinoid, it is essential to approach it with caution and to study its properties more thoroughly.
D9 (Delta-9-Tetrahydrocannabinol)
D9, commonly known as delta-9-THC, is the best-known and most abundant psychoactive cannabinoid in cannabis. At high doses, it is responsible for the euphoria associated with cannabis use. Permitted at levels up to 0.3% in hemp-derived products, its effects generally work in conjunction with non-psychotropic cannabinoids.
As the hemp industry evolves, exploring these lesser-known cannabinoids offers consumers exciting opportunities to diversify their experiences. It is essential to remember that research on these cannabinoids is ongoing and that their effects may vary from person to person. If you’re considering trying one of these products, it’s advisable to start with low doses and consult a healthcare professional if you have any underlying health conditions.
Dr Cannabinoid is committed to providing accurate information and high-quality products to its customers. As with all of its offerings, THCP, THCV, H4CBD, and D9 products undergo rigorous testing to ensure their safety and compliance with industry standards.
With DrCannabinoid.fr, fans of hemp-derived products can now explore the fascinating world of legal recreational cannabinoid-based products.
-
Business2 weeks ago
The legal cannabis market in New York exceeds 4 billion $ in revenue
-
Cannabis in France4 weeks ago
Which countries legalized medical cannabis before France?
-
Business4 weeks ago
South Korea is preparing to begin local production of medical cannabis to meet rising demand
-
Cannabis in France4 days ago
France already has 3,000 cannabis retail outlets. None of them are legal.
-
Cannabis in Thailand4 weeks ago
From the boom in dispensaries to a purely medical approach: Thailand is revising its cannabis policy
-
Cannabis in the U.S.5 days ago
A DEA report confirms that there are no fatal cannabis overdoses
-
Cannabis and driving3 weeks ago
Medical Cannabis and Driving: New South Wales Ends Automatic Penalties for THC
-
Cannabis in France3 weeks ago
France’s Drug Policy Chief Defends Cannabis Prohibition... and Runs Into the Facts


You must be logged in to post a comment Login